Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by culateron Feb 13, 2012 3:40pm
277 Views
Post# 19527368

Compare to ONTY

Compare to ONTY

Bought another Edmonton company, Biomira, around the same time as ISA some 10+ years ago.  I pretty much wrote this investment off as well.    Biomira packed their bags and headed to the U.S., changed the name to Oncothyreon Inc., did a reverse split, 1 share for 4 and trades on the NASDAQ.  The info on the drugs seems similar to ISA in the development stage,  but the past six months have presented an opportunity to at least break even on ONTY with constant activity.  Better Management?  Doesn't seem to be a whole lot better press on them.   Any comments?

culater

<< Previous
Bullboard Posts
Next >>